Pharmafile Logo
Pharmafocus logo
Advanced Search
EU flag

European Commission funds €23m project to develop HIV vaccine

November 2, 2015
Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020

The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …

News
eylea

Bayer, Regeneron’s Eylea gets additional EU indication

November 2, 2015
Research and Development, Sales and Marketing Bayer, Eylea, Regeneron

The European Commission has granted a fifth indication to Bayer and Regeneron’s eye drug Eylea (aflibercept injection), which is now …

News
Vidaza product image

Celgene’s Vidaza earns wider approval

November 2, 2015
Sales and Marketing Celgene, European Commission, Vidaza, acute myeloid leukaemia, azacitidine, leukaemia

Swiss firm Celgene has been given approval by the European Commission to extend its marketing authorisation for the cancer treatment …

News
Merck R&D

Merck and Selvita form oncology partnership

November 2, 2015
Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology

Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …

News
abbvie_0

AbbVie reports 26% rise in Q3 revenues

October 30, 2015
Sales and Marketing AbbVie, Humira

AbbVie has announced stronger-than-anticipated Q3 financial results, its revenues increasing 26.2% on the same period last year to $5.944 billion, …

News
pillsphotos1

The pharmaceutical ethics of drug-price increases

October 30, 2015
Medical Communications, Research and Development Drug pricing, Turing Pharma, ethics

What is an ‘ethical’ price for a drug?Last month Turing Pharmaceuticals, a start-up run by a former hedge-fund manager, raised …

Feature
Phase III trial

FDA approves new therapy for pancreatic cancer

October 30, 2015
Medical Communications, Sales and Marketing FDA, Pancreatic cancer

The FDA has approved drug a pancreatic cancer drug, Onivyde, which has produced significant overall survival rates in an international …

News
valeant_logo

Valeant drops Philidor after prescription fraud row

October 30, 2015
Medical Communications, Sales and Marketing Valeant

Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …

News

NHS set for digital health tech review

October 30, 2015
Medical Communications Jeremy Hunt, NHS, Robert Wachter, digital health, health secretary

Health secretary Jeremy Hunt says turning the NHS into a “patient-powered, technologically advanced health service” is “one of the most …

News
Project EVO

Digital software shows benefit in ADHD trial

October 30, 2015
Medical Communications ADHD, Akili, PureTech Health, attention deficit hyperactivity disorder, digital tech

A pilot study of a digital health technology designed to improve symptoms of attention deficit hyperactivity disorder (ADHD) in children …

News
sanofi_logo_vertical_2011_4colors-web

Sanofi recalls allergy injection pens

October 29, 2015
Manufacturing and Production Allerject, Sanofi, anaphylaxis

Sanofi has halted manufacturing and is recalling its Allerject auto-injectors following a blunder involving incorrect dosages. The voluntary recall involves …

News
faysal_kamoua

Alvogen appoints Faysal Kalmoua as EVP of portfolio

October 29, 2015
Medical Communications Alvogen, Faysal Kalmoua

Alvogen has announced the appointment of Faysal Kalmoua as its new executive vice president of portfolio.Kalmoua joins Alvogen with an …

Appointment
Constella

Allergan acquires rights to pioneering IBS treatment from Almirall

October 29, 2015
Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide

Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …

News
Coins

ANALYSIS: The challenges of forecasting biosimilar sales across Europe

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts

The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …

Feature
Yervoy

FDA approves Bristol-Myers Squibb’s skin cancer drug

October 29, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilumumab, melanoma

The FDA has recommended Bristol-Myers Squibb’s cancer drug Yervoy (ipilimumab) for the adjuvant treatment of patients with melanoma. The drug, …

News
novo_nordisk

Novo Nordisk posts strong nine-month results

October 29, 2015
Sales and Marketing Novo Nordisk, insulin

Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …

News

Bayer posts strong earnings growth

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Sales across the Bayer group rose by 1.9% in the third quarter of 2015 to €11 billion, according the company’s …

News
novartis

Novartis launches new hypertension program in Ghana

October 29, 2015
Research and Development

The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in …

News
allergan_pfizer_logos

Pfizer in ‘friendly’ merger talks with Allergan

October 29, 2015
Sales and Marketing Actavis, Allergan, Pfizer, Teva

Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …

News
jose_joe_almeida

Baxter names José Almeida chairman and chief executive

October 29, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter

Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …

Appointment
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026